| Kimberly A Apker, MD | |
|
13819 Gold Circle, Omaha, NE 68144 | |
| (402) 330-6550 | |
| Not Available |
| Full Name | Kimberly A Apker |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 33 Years |
| Location | 13819 Gold Circle, Omaha, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649209776 | NPI | - | NPPES |
| 31732 | Other | NE | BCBS |
| 6915710 | Medicaid | IA | |
| 1600523 | Other | UHC SHARE ALLIANCE | |
| 9108 | Other | MIDLANDS | |
| 1600110 | Other | UHC SHARE ALLIANCE | |
| 5915710 | Medicaid | IA | |
| 19067 | Other | IA | BCBS |
| 2915710 | Medicaid | IA | |
| 7915710 | Medicaid | IA | |
| 8915710 | Medicaid | IA | |
| BA6847086 | Other | IA CONTROLLED SUBSTANCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 33448 (Iowa) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 18912 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Bellevue Medical Center | Bellevue, NE | Hospital |
| Nebraska Orthopaedic Hospital | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unmc Physicians | 6002728391 | 1320 |
News Archive
Biomaterials and medical devices must be rigorously tested in the laboratory before they may be implanted into test subjects. By ensuring that these test methods are both quick and efficient, an increased number of materials can be tested and working implants can be produced more rapidly. The development of such tests is therefore essential to biomedical advancement, and Characterization of biomaterials reviews the latest methods for defining properties and characterizing materials. Characterization of biomaterials discusses a wide array of techniques and various unique approaches to the problems faced in characterizing biomaterials, whilst also providing information on standards and methods for assessing the safety and biocompatibility of biomaterials.
Reported mid-life increase in body mass index (BMI) may lead to substantially higher risk of postmenopausal breast cancer, according to results of a prospective cohort study presented at the American Association for Cancer Research 101st Annual Meeting 2010, held here April 17-21.
Emergent BioSolutions Inc. announced today that it was awarded a cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to further the development of one of Emergent's advanced anthrax vaccine candidates known as dmPA7909.
The ERC Advanced Grant is one of the most prestigious funding programmes for research in Europe. Per-Olof Berggren, professor of experimental endocrinology at Karolinska Institutet, is now awarded this grant for the second time.
› Verified 8 days ago
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
Biomaterials and medical devices must be rigorously tested in the laboratory before they may be implanted into test subjects. By ensuring that these test methods are both quick and efficient, an increased number of materials can be tested and working implants can be produced more rapidly. The development of such tests is therefore essential to biomedical advancement, and Characterization of biomaterials reviews the latest methods for defining properties and characterizing materials. Characterization of biomaterials discusses a wide array of techniques and various unique approaches to the problems faced in characterizing biomaterials, whilst also providing information on standards and methods for assessing the safety and biocompatibility of biomaterials.
Reported mid-life increase in body mass index (BMI) may lead to substantially higher risk of postmenopausal breast cancer, according to results of a prospective cohort study presented at the American Association for Cancer Research 101st Annual Meeting 2010, held here April 17-21.
Emergent BioSolutions Inc. announced today that it was awarded a cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to further the development of one of Emergent's advanced anthrax vaccine candidates known as dmPA7909.
The ERC Advanced Grant is one of the most prestigious funding programmes for research in Europe. Per-Olof Berggren, professor of experimental endocrinology at Karolinska Institutet, is now awarded this grant for the second time.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly A Apker, MD Po Box 4460, Omaha, NE 68104 Ph: (866) 491-5807 | Kimberly A Apker, MD 13819 Gold Circle, Omaha, NE 68144 Ph: (402) 330-6550 |
News Archive
Biomaterials and medical devices must be rigorously tested in the laboratory before they may be implanted into test subjects. By ensuring that these test methods are both quick and efficient, an increased number of materials can be tested and working implants can be produced more rapidly. The development of such tests is therefore essential to biomedical advancement, and Characterization of biomaterials reviews the latest methods for defining properties and characterizing materials. Characterization of biomaterials discusses a wide array of techniques and various unique approaches to the problems faced in characterizing biomaterials, whilst also providing information on standards and methods for assessing the safety and biocompatibility of biomaterials.
Reported mid-life increase in body mass index (BMI) may lead to substantially higher risk of postmenopausal breast cancer, according to results of a prospective cohort study presented at the American Association for Cancer Research 101st Annual Meeting 2010, held here April 17-21.
Emergent BioSolutions Inc. announced today that it was awarded a cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to further the development of one of Emergent's advanced anthrax vaccine candidates known as dmPA7909.
The ERC Advanced Grant is one of the most prestigious funding programmes for research in Europe. Per-Olof Berggren, professor of experimental endocrinology at Karolinska Institutet, is now awarded this grant for the second time.
› Verified 8 days ago
Dr. Timothy Edward Donovan, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-1010 Fax: 102-559-1011 | |
Mary S. Davey, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St Ste 3601, Omaha, NE 68131 Phone: 402-449-4540 | |
Craig W Walker, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-1010 Fax: 402-559-1011 | |
Steven T Mccormack, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 17310 Wright St Ste 103, Omaha, NE 68130 Phone: 833-228-6889 Fax: 877-853-0376 | |
John Paul Haas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-1010 Fax: 402-559-1011 | |
Andrew Greer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7268 | |
Sushama P Kunnathil, MBBS Radiology Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-1010 Fax: 402-559-1011 |